Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET

Company Participants

Dana Lynch - Director of Corporate Communications & Corporate Affairs

Peter Greenleaf - President & Chief Executive Officer

Joe Miller - Chief Financial Officer

Max Colao - Chief Commercial Officer

Neil Solomons - Chief Medical Officer

Conference Call Participants

Olivia Brayer - Cantor Fitzgerald

Maury Raycroft - Jeffries

Stacy Ku - Cowen and Company

Ed Arce - HC Wainwright

Sahil Dhingra - RBC

David Martin - Bloom Burton

Justin Kim - Oppenheimer

Operator

Greetings, and welcome to the Aurinia Pharmaceuticals First Quarter 2022 Financial and Operational Results Conference Call. At this time all participants are in a listen-only mode and a question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Dana Lynch, Aurinia's Senior Director of Corporate Communications and Corporate Affairs. Thank you. Dana, you may begin.

Dana Lynch

Thank you, James, and thank you all for joining today's call and webcast to discuss Aurinia's first quarter 2022 financial results. Joining me this morning are Peter Greenleaf, President and CEO; Joe Miller, Chief Financial Officer, who will be leading the call. Other members of the executive team, specifically, Max Colao, Chief Commercial Officer; and Dr. Neil Solomons, Chief Medical Officer, will also be available at the conclusion of our prepared remarks for the Q&A portion of the call.

This morning, we issued a press release announcing our financial results and recent operational highlights and filed our quarterly report on Form 10-Q. For more information, please refer to our filings with the U.S. Securities and Exchange Commission, which are also available on our website at www.auriniapharma.com.

During this call, we will make forward-looking statements based on our current expectations. These forward-looking statements are subject to a number of significant risks and uncertainties, and our actual results may differ materially. For a discussion of factors that could affect our future financial results and business, please refer to the disclosures in our press release and our quarterly report on Form 10-Q, along with our 10-K and all of our recent filings with the U.S. Securities and Exchange Commission and Canadian Securities Authorities.

Please note that all statements made during today's call are current as of today, May 10, 2022, unless otherwise noted and are based upon information currently available to us at this time. Except as required by law, we assume no obligation to update any such statements.